VINC (Vincerx Pharma) Float Percentage Of Total Shares Outstanding: 96.44% (As of Jun. 30, 2026)


What is Vincerx Pharma Float Percentage Of Total Shares Outstanding?

Vincerx Pharma VINC Float Percentage Of Total Shares Outstanding is 96.44% as of Jun. 30, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vincerx Pharma's float shares is 5.04 Mil. Vincerx Pharma's total shares outstanding is 5.23 Mil. Vincerx Pharma's float percentage of total shares outstanding is 96.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vincerx Pharma's Insider Ownership is 77.46%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vincerx Pharma's Institutional Ownership is 2.59%.

Vincerx Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Vincerx Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.04/5.23
=96.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 96.44% mean?
Vincerx Pharma (VINC) has a Float Percentage Of Total Shares Outstanding of 96.44% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Vincerx Pharma and its competitors.
Is Vincerx Pharma's Float Percentage Of Total Shares Outstanding too high?
Vincerx Pharma's current Float Percentage Of Total Shares Outstanding is 96.44%.
How does Vincerx Pharma's Float Percentage Of Total Shares Outstanding compare to SYGGF and CNBX?
Vincerx Pharma's Float Percentage Of Total Shares Outstanding of 96.44% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Vincerx Pharma and its competitors. Vincerx Pharma's current Float Percentage Of Total Shares Outstanding is 96.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vincerx Pharma stock overvalued right now?
Vincerx Pharma (VINC) has a current Float Percentage Of Total Shares Outstanding of 96.44%. The current Float Percentage Of Total Shares Outstanding is 96.44%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Vincerx Pharma (VINC), the current Float Percentage Of Total Shares Outstanding is 96.44% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vincerx Pharma Business Description

Address 1825 S. Grant Street, San Mateo, CA, USA, 94402
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.